FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385740300> ?p ?o ?g. }

• W4385740300 abstract "Abstract Introduction Type 2 diabetes mellitus (T2DM) is a non-communicable disease representing one of the most serious public health challenges of the twenty-first century. Its incidence continues to rise in both developed and developing countries, causing the death of 1.5 million people every year. The use of technology (e.g. smartphone application—App) in the health field has progressively increased as it has been proved to be effective in helping individuals manage their long-term diseases. Therefore, it has the potential to reduce the use of health service and its related costs. The objective of this study is to evaluate the impact of using a digital platform called “TreC Diabete” embedded into a novel organisational asset targeting poorly controlled T2DM individuals in the Autonomous Province of Trento (PAT), Italy. Methods This trial was designed as a multi-centre, open-label, randomised, superiority study with two parallel groups and a 1:1 allocation ratio. Individuals regularly attending outpatient diabetes clinics, providing informed consent, are randomised to be prescribed TreC Diabete platform as part of their personalised care plan. Healthcare staff members will remotely assess the data shared by the participants through the App by using a dedicated online medical dashboard. The primary end-point is the evaluation of the Hb1Ac level at 12-month post-randomisation. Data will be analysed on an intention-to-treat (ITT) basis. Discussion This trial is the first conducted in the PAT area for the use of an App specifically designed for individuals with poorly controlled T2DM. If the effects of introducing this specific App within a new organisational asset are positive, the digital platform will represent a possible way for people diagnosed with T2DM to better manage their health in the future. Results will be disseminated through conferences and peer-reviewed journals once the study is completed. Trial registration ClinicalTrials.gov NCT05629221. Registered on November 29, 2022, prior start of inclusion." @default.
• W4385740300 created "2023-08-11" @default.
• W4385740300 creator A5000601832 @default.
• W4385740300 creator A5005754992 @default.
• W4385740300 creator A5007101056 @default.
• W4385740300 creator A5008961543 @default.
• W4385740300 creator A5014053030 @default.
• W4385740300 creator A5015233897 @default.
• W4385740300 creator A5018761244 @default.
• W4385740300 creator A5018999962 @default.
• W4385740300 creator A5027799599 @default.
• W4385740300 creator A5038158005 @default.
• W4385740300 creator A5043644344 @default.
• W4385740300 creator A5056472181 @default.
• W4385740300 creator A5062860473 @default.
• W4385740300 creator A5070706296 @default.
• W4385740300 creator A5074956229 @default.
• W4385740300 creator A5092626033 @default.
• W4385740300 creator A5092626034 @default.
• W4385740300 date "2023-08-10" @default.
• W4385740300 modified "2023-10-14" @default.
• W4385740300 title "Organisational models supported by technology for the management of diabetic disease and its complications in a diabetic clinic setting: study protocol for a randomised controlled trial targeting type 2 diabetes individuals with non-ideal glycaemic values (Telemechron study)" @default.
• W4385740300 cites W1964910145 @default.
• W4385740300 cites W2031756259 @default.
• W4385740300 cites W2049034520 @default.
• W4385740300 cites W2056914680 @default.
• W4385740300 cites W2072335042 @default.
• W4385740300 cites W2155965977 @default.
• W4385740300 cites W2171129594 @default.
• W4385740300 cites W2171811563 @default.
• W4385740300 cites W2172151487 @default.
• W4385740300 cites W2344301036 @default.
• W4385740300 cites W2396978483 @default.
• W4385740300 cites W2551745341 @default.
• W4385740300 cites W2592184816 @default.
• W4385740300 cites W2595307528 @default.
• W4385740300 cites W2607031541 @default.
• W4385740300 cites W2622555729 @default.
• W4385740300 cites W2809266094 @default.
• W4385740300 cites W2888589263 @default.
• W4385740300 cites W2926642108 @default.
• W4385740300 cites W2953804067 @default.
• W4385740300 cites W2991004728 @default.
• W4385740300 cites W3092836078 @default.
• W4385740300 cites W3156790350 @default.
• W4385740300 cites W3159078634 @default.
• W4385740300 cites W3163715371 @default.
• W4385740300 cites W3170631548 @default.
• W4385740300 cites W3183857127 @default.
• W4385740300 cites W3193598686 @default.
• W4385740300 cites W3196615344 @default.
• W4385740300 cites W3000276845 @default.
• W4385740300 doi "https://doi.org/10.1186/s13063-023-07515-6" @default.
• W4385740300 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37563665" @default.
• W4385740300 hasPublicationYear "2023" @default.
• W4385740300 type Work @default.
• W4385740300 citedByCount "0" @default.
• W4385740300 crossrefType "journal-article" @default.
• W4385740300 hasAuthorship W4385740300A5000601832 @default.
• W4385740300 hasAuthorship W4385740300A5005754992 @default.
• W4385740300 hasAuthorship W4385740300A5007101056 @default.
• W4385740300 hasAuthorship W4385740300A5008961543 @default.
• W4385740300 hasAuthorship W4385740300A5014053030 @default.
• W4385740300 hasAuthorship W4385740300A5015233897 @default.
• W4385740300 hasAuthorship W4385740300A5018761244 @default.
• W4385740300 hasAuthorship W4385740300A5018999962 @default.
• W4385740300 hasAuthorship W4385740300A5027799599 @default.
• W4385740300 hasAuthorship W4385740300A5038158005 @default.
• W4385740300 hasAuthorship W4385740300A5043644344 @default.
• W4385740300 hasAuthorship W4385740300A5056472181 @default.
• W4385740300 hasAuthorship W4385740300A5062860473 @default.
• W4385740300 hasAuthorship W4385740300A5070706296 @default.
• W4385740300 hasAuthorship W4385740300A5074956229 @default.
• W4385740300 hasAuthorship W4385740300A5092626033 @default.
• W4385740300 hasAuthorship W4385740300A5092626034 @default.
• W4385740300 hasBestOaLocation W43857403001 @default.
• W4385740300 hasConcept C134018914 @default.
• W4385740300 hasConcept C141071460 @default.
• W4385740300 hasConcept C142724271 @default.
• W4385740300 hasConcept C159110408 @default.
• W4385740300 hasConcept C160735492 @default.
• W4385740300 hasConcept C162324750 @default.
• W4385740300 hasConcept C168563851 @default.
• W4385740300 hasConcept C204787440 @default.
• W4385740300 hasConcept C27415008 @default.
• W4385740300 hasConcept C2779134260 @default.
• W4385740300 hasConcept C2779363104 @default.
• W4385740300 hasConcept C2780385302 @default.
• W4385740300 hasConcept C2780433410 @default.
• W4385740300 hasConcept C2910068830 @default.
• W4385740300 hasConcept C50522688 @default.
• W4385740300 hasConcept C512399662 @default.
• W4385740300 hasConcept C555293320 @default.
• W4385740300 hasConcept C71924100 @default.
• W4385740300 hasConceptScore W4385740300C134018914 @default.
• W4385740300 hasConceptScore W4385740300C141071460 @default.
• W4385740300 hasConceptScore W4385740300C142724271 @default.
• W4385740300 hasConceptScore W4385740300C159110408 @default.
• W4385740300 hasConceptScore W4385740300C160735492 @default.
• W4385740300 hasConceptScore W4385740300C162324750 @default.

• next